桡动脉与隐静脉与右胸廓内动脉用于冠状动脉旁路移植术的比较
该研究汇总4项大型冠状动脉旁路移植术试验的个体患者数据,比较桡动脉、右胸廓内动脉或隐静脉作为左胸廓内动脉-左前降支桥血管补充材料的长期结局。共纳入10256例患者,倾向性评分匹配后形成1776个三联配对。桡动脉组全因死亡率和主要不良心脑血管事件率均低于隐静脉组和右胸廓内动脉组。
要点
- 桡动脉组全因死亡率显著低于隐静脉组(HR 0.62,95%CI 0.51-0.76,P=0.003)和右胸廓内动脉组(HR 0.59,95%CI 0.48-0.71,P=0.001)。
- 桡动脉组主要不良心脑血管事件率低于隐静脉组(HR 0.78,95%CI 0.67-0.90,P=0.04)和右胸廓内动脉组(HR 0.75,95%CI 0.65-0.86,P=0.02)。
- Cox校正分析和隐藏混杂因素敏感性分析结果一致。
核心结论
- 在这项4项大型冠状动脉旁路移植术试验的汇总分析中,与隐静脉和右胸廓内动脉相比,使用桡动脉与更好的临床结局相关。
研究设计与样本
- 研究使用4项最大型当代冠状动脉旁路移植术试验的个体患者数据进行汇总分析,共纳入10256例患者(右胸廓内动脉组1510例,桡动脉组1385例,隐静脉组7361例)。
- 采用倾向性评分匹配和Cox回归减少治疗选择偏倚和混杂因素的影响,匹配后人群包括1776个倾向性评分三联配对。
- 右胸廓内动脉组、桡动脉组和隐静脉组的平均随访时间分别为7.9±0.1年、7.8±0.1年和7.8±0.1年。
主要发现
- 桡动脉组全因死亡率显著低于隐静脉组(HR 0.62,95%CI 0.51-0.76,P=0.003),也显著低于右胸廓内动脉组(HR 0.59,95%CI 0.48-0.71,P=0.001)。
- 桡动脉组主要不良心脑血管事件率低于隐静脉组(HR 0.78,95%CI 0.67-0.90,P=0.04),也低于右胸廓内动脉组(HR 0.75,95%CI 0.65-0.86,P=0.02)。
- Cox校正分析结果一致,且对隐藏混杂因素稳健。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We used individual patient data from 4 of the largest contemporary coronary bypass surgery trials to evaluate differences in long-term outcomes when radial artery (RA), right internal thoracic artery (RITA) or saphenous vein graft (SVG) are used to complement the left internal thoracic artery-to-left anterior descending graft. METHODS: Primary outcome was all-cause mortality. Secondary outcome was a composite of major adverse cardiac and cerebrovascular events (all-cause mortality, myocardial infarction and stroke). Propensity score matching and Cox regression were used to reduce the effect of treatment selection bias and confounders. RESULTS: A total of 10 256 patients (1510 RITA; 1385 RA; 7361 SVG) were included. The matched population consisted of 1776 propensity score-matched triplets. The mean follow-up was 7.9 ± 0.1, 7.8 ± 0.1 and 7.8 ± 0.1 years in the RITA, RA and SVG cohorts respectively. All-cause mortality was significantly lower in the RA versus the SVG [hazard ratio (HR) 0.62, 95% confidence interval (CI): 0.51-0.76, P = 0.003] and the RITA group (HR 0.59, 95% CI 0.48-0.71, P = 0.001). Major adverse cardiac and cerebrovascular event rate was also lower in the RA group versus the SVG (HR 0.78, 95% CI 0.67-0.90, P = 0.04) and the RITA group (HR 0.75, 95% CI 0.65-0.86, P = 0.02). Results were consistent in the Cox-adjusted analysis and solid to hidden confounders. CONCLUSIONS: In this pooled analysis of 4 large coronary bypass surgery trials, the use of the RA was associated with better clinical outcomes when compared to SVG and RITA.
引用
- Gaudino M, Audisio K, Di Franco A, et al. Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. Eur J Cardiothorac Surg. 2022. PMID: 35678560. doi:10.1093/ejcts/ezac345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。